This was confirmed in a multicentre retrospective data collection study [29], which showed that MYC + BCL6 DH lymphoma does not represent high-risk lymphoma, while MYC + BCL2 DH lymphoma has particularly poor prognosis (Fig. 2D). This evidence concerns the gene BCL2 and lymphoma.